The article mentions that NIO's stock is trading lower due to concerns over a COVID wave in China and its impact on the country's economic recovery. This could potentially affect the company's performance, as it operates in the Chinese market. The respiratory disease specialist Zhong Nanshan's projection of 65 million cases per week by the end of June adds to the concerns, which could negatively impact NIO's stock price in the short term.